TruScreen Unveils AI-Powered Cervical Cancer Screening for 260,000 Women in Vietnam

A Strategic Public Health Initiative

TruScreen Group Limited (NZX/ASX: TRU) has officially launched an ambitious five-year cervical cancer screening program in Ho Chi Minh City, Vietnam, aiming to screen 260,000 women using its innovative AI-enabled, real-time, non-invasive screening device. This initiative, announced on April 22, 2025, represents a significant step forward in addressing cervical cancer detection challenges in a region where screening rates remain low.

The program, titled the 'Community-based Cervical Cancer Screening Program,' is a collaborative effort between TruScreen, the Ho Chi Minh City Public Health Association (HPHA), and local distributor Gorton Health Services (GHS). The partnership was formalized through a Memorandum of Understanding signed in November 2024, followed by a program agreement in April 2025.

Leveraging AI for Early Detection

TruScreen’s device stands out for its unique ability to deliver immediate, accurate cervical cancer screening results without the need for cytology or laboratory infrastructure. Its AI-enabled algorithm analyses optical and electrical signals from cervical tissue, enabling a non-invasive and portable screening process. This technology aligns perfectly with the program’s goal of expanding access to early detection in large, community-based populations.

Vietnam’s government has set a national target to screen 60% of women aged 30 to 54 by 2025, a significant increase from the current 25%. TruScreen’s technology is positioned as a critical enabler to meet this target, especially given the country’s large addressable population of 36 million women aged 18 to 65.

Community Engagement and Program Delivery

HPHA will oversee the program’s implementation, including community outreach and recruitment of social workers who will educate women door-to-door about cervical cancer risks and screening benefits. The program prioritizes women aged 30 to 49 with higher risk factors such as HPV infection, multiple childbirths, or smoking.

Screening will be conducted at district health centers and private clinics, supported by major hospitals including Tu Du, Hung Vuong, and Ung Buou. Media support from the Ho Chi Minh City Women's Union will further promote awareness and participation.

Broader Implications and Future Prospects

TruScreen CEO Marty Dillon highlighted the program’s potential to save thousands of lives by increasing early detection rates. The initiative also serves as a model for neighboring countries considering similar large-scale screening programs. With over 200,000 examinations performed globally in 2024 and regulatory approvals across multiple countries, TruScreen is well-positioned to expand its footprint in Asia and beyond.

While financial details of the program remain undisclosed, the partnership and scale suggest meaningful commercial and social impact. The program’s success will depend on effective execution, community engagement, and the ability to scale beyond Ho Chi Minh City to other provinces.